APA (7th ed.) Citation

Eteläinen, T., Silva, M. C., Uhari-Väänänen, J. K., De Lorenzo, F., Jäntti, M. H., Cui, H., . . . Myöhänen, T. T. (2023). A prolyl oligopeptidase inhibitor reduces tau pathology in cellular models and in mice with tauopathy. Science translational medicine, 15(691), . https://doi.org/10.1126/scitranslmed.abq2915

Chicago Style (17th ed.) Citation

Eteläinen, Tony, et al. "A Prolyl Oligopeptidase Inhibitor Reduces Tau Pathology in Cellular Models and in Mice with Tauopathy." Science Translational Medicine 15, no. 691 (2023). https://doi.org/10.1126/scitranslmed.abq2915.

MLA (9th ed.) Citation

Eteläinen, Tony, et al. "A Prolyl Oligopeptidase Inhibitor Reduces Tau Pathology in Cellular Models and in Mice with Tauopathy." Science Translational Medicine, vol. 15, no. 691, 2023, https://doi.org/10.1126/scitranslmed.abq2915.